Related Experiment Videos

The use of augmentin in hospitalized and ambulatory children

R Raz1, R Halevy, Y Antonelli

  • 1Infectious Diseases Unit, Central Emek Hospital, Afula, Israel.

Insights

Augmentin (amoxicillin/clavulanate) effectively treated common bacterial infections in children, achieving a 90% cure rate with a low side-effect profile. This demonstrates its safety and efficacy for pediatric patients.

Area of Science:

  • Pediatric infectious diseases
  • Pharmacology and therapeutics
  • Bacterial infection treatment

Background:

  • Bacterial infections are common in pediatric populations.
  • Effective and safe antibiotic options are crucial for treating children.
  • Augmentin is a widely used antibiotic for various infections.

Purpose of the Study:

  • To evaluate the efficacy and safety of Augmentin in treating common bacterial infections in pediatric patients.
  • To assess clinical and microbiological cure rates.
  • To compare the side-effect profile with other antimicrobial agents.

Main Methods:

  • A study involving 40 pediatric patients (26 hospitalized, 14 ambulatory) with common bacterial infections.
  • Treatment administered included Augmentin, both intravenously and orally.
  • Clinical and microbiological outcomes were monitored.

Main Results:

  • A high clinical and microbiological cure rate of 90% was achieved.
  • The incidence of side-effects was comparable to other commonly used antibiotics.
  • No significant adverse events were reported.

Conclusions:

  • Augmentin is a safe and effective treatment option for common bacterial infections in children.
  • The drug demonstrated a favorable efficacy and safety profile in the pediatric population.
  • Augmentin can be reliably used in both hospitalized and ambulatory pediatric patients.

Related Concept Videos